Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
14
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Davidson Aaron | Director | 1 | $0 | $0 | 2012-08-07 |
| Garg Vipin K | President & CEO | 1 | $0 | $0 | 2012-08-07 |
| Eisenstadt Richard I | VP, Finance & CFO | 1 | $0 | $0 | 2012-08-07 |
| Castaigne Jean-Paul | Director | 1 | $0 | $0 | 2012-08-07 |
| Thomas Helmut | Senior VP, R&D | 1 | $0 | $0 | 2012-08-07 |
| Zisson Alex | Director | 1 | $0 | $0 | 2012-08-07 |
| ABERCROMBIE GEORGE B | Director | 1 | $0 | $0 | 2012-08-07 |
| JOHNSON JOHN | Director | 1 | $0 | $0 | 2012-08-07 |
| VANLENT ANNE | Director | 1 | $0 | $0 | 2012-08-07 |
| ROUSSEAU FRANCK | Chief Medical Officer | 2 | $0 | $0 | 2012-08-07 |
| Moore David | VP, Commercial Operations | 1 | $0 | $0 | 2012-04-19 |
| Baker Biotech Capital (GP), LLC | 10% Owner | 7 | $312.1K | $0 | 2012-03-14 |
| BAKER FELIX | 10% Owner | 7 | $3.08M | $0 | 2012-03-14 |
| BAKER JULIAN | 10% Owner | 7 | $81.2K | $0 | 2012-03-14 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| ABERCROMBIE GEORGE B | Director | A Award deriv | 2012-08-07 | 2012-08-09 | 31,835 | — | $0 | 31,835 | SEC↗ |
| JOHNSON JOHN | Director | A Award deriv | 2012-08-07 | 2012-08-09 | 21,044 | — | $0 | 21,044 | SEC↗ |
| Zisson Alex | Director | A Award deriv | 2012-08-07 | 2012-08-09 | 31,835 | — | $0 | 31,835 | SEC↗ |
| Garg Vipin K | President & CEO | A Award deriv | 2012-08-07 | 2012-08-09 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ROUSSEAU FRANCK | Chief Medical Officer | A Award deriv | 2012-08-07 | 2012-08-09 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Castaigne Jean-Paul | Director | A Award deriv | 2012-08-07 | 2012-08-09 | 26,448 | — | $0 | 26,448 | SEC↗ |
| VANLENT ANNE | Director | A Award deriv | 2012-08-07 | 2012-08-09 | 31,835 | — | $0 | 31,835 | SEC↗ |
| Davidson Aaron | Director | A Award deriv | 2012-08-07 | 2012-08-09 | 31,835 | — | $0 | 31,835 | SEC↗ |
| Eisenstadt Richard I | VP, Finance & CFO | A Award deriv | 2012-08-07 | 2012-08-09 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Thomas Helmut | Senior VP, R&D | A Award deriv | 2012-08-07 | 2012-08-09 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Moore David | VP, Commercial Operations | A Award deriv | 2012-04-19 | 2012-04-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ROUSSEAU FRANCK | Chief Medical Officer | A Award deriv | 2012-04-19 | 2012-04-23 | 100,000 | — | $0 | 100,000 | SEC↗ |
| BAKER JULIAN | 10% Owner | P Buy | 2012-03-14 | 2012-03-14 | 1,482 | $2.99 | $4.4K | 56,794 | SEC↗ |
| BAKER JULIAN | 10% Owner | P Buy | 2012-03-14 | 2012-03-14 | 910 | $3.01 | $2.7K | 57,704 | SEC↗ |
| Baker Biotech Capital (GP), LL | 10% Owner | P Buy | 2012-03-14 | 2012-03-14 | 4,592 | $3.01 | $13.8K | 232,011 | SEC↗ |
| Baker Biotech Capital (GP), LL | 10% Owner | P Buy | 2012-03-14 | 2012-03-14 | 7,484 | $2.99 | $22.4K | 227,419 | SEC↗ |
| BAKER FELIX | 10% Owner | P Buy | 2012-03-14 | 2012-03-14 | 56,294 | $2.99 | $168.3K | 3,505,471 | SEC↗ |
| BAKER FELIX | 10% Owner | P Buy | 2012-03-14 | 2012-03-14 | 34,544 | $3.01 | $104.0K | 3,540,015 | SEC↗ |
| BAKER JULIAN | 10% Owner | P Buy | 2012-03-13 | 2012-03-14 | 4,186 | $2.96 | $12.4K | 55,312 | SEC↗ |
| Baker Biotech Capital (GP), LL | 10% Owner | P Buy | 2012-03-13 | 2012-03-14 | 15,599 | $2.96 | $46.2K | 219,935 | SEC↗ |
| BAKER FELIX | 10% Owner | P Buy | 2012-03-13 | 2012-03-14 | 159,015 | $2.96 | $470.7K | 3,449,177 | SEC↗ |
| BAKER JULIAN | 10% Owner | P Buy | 2012-03-12 | 2012-03-14 | 15,076 | $2.55 | $38.4K | 51,126 | SEC↗ |
| BAKER JULIAN | 10% Owner | P Buy | 2012-03-12 | 2012-03-14 | 8,628 | $2.34 | $20.2K | 36,050 | SEC↗ |
| BAKER JULIAN | 10% Owner | P Buy | 2012-03-12 | 2012-03-14 | 1,170 | $1.87 | $2.2K | 27,422 | SEC↗ |
| BAKER JULIAN | 10% Owner | P Buy | 2012-03-12 | 2012-03-14 | 430 | $1.89 | $813 | 26,252 | SEC↗ |
| Baker Biotech Capital (GP), LL | 10% Owner | P Buy | 2012-03-12 | 2012-03-14 | 1,601 | $1.89 | $3.0K | 111,631 | SEC↗ |
| Baker Biotech Capital (GP), LL | 10% Owner | P Buy | 2012-03-12 | 2012-03-14 | 4,363 | $1.87 | $8.2K | 115,994 | SEC↗ |
| Baker Biotech Capital (GP), LL | 10% Owner | P Buy | 2012-03-12 | 2012-03-14 | 32,155 | $2.34 | $75.2K | 148,149 | SEC↗ |
| Baker Biotech Capital (GP), LL | 10% Owner | P Buy | 2012-03-12 | 2012-03-14 | 56,187 | $2.55 | $143.3K | 204,336 | SEC↗ |
| BAKER FELIX | 10% Owner | P Buy | 2012-03-12 | 2012-03-14 | 572,737 | $2.55 | $1.46M | 3,290,162 | SEC↗ |
| BAKER FELIX | 10% Owner | P Buy | 2012-03-12 | 2012-03-14 | 327,769 | $2.34 | $767.0K | 2,717,425 | SEC↗ |
| BAKER FELIX | 10% Owner | P Buy | 2012-03-12 | 2012-03-14 | 44,467 | $1.87 | $83.2K | 2,389,656 | SEC↗ |
| BAKER FELIX | 10% Owner | P Buy | 2012-03-12 | 2012-03-14 | 16,326 | $1.89 | $30.9K | 2,345,189 | SEC↗ |